These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 3325760)
1. Synthesis and mutagenicity of selectively methylated analogs of tris(2,3-dibromopropyl)phosphate and 1,2-dibromo-3-chloropropane. Omichinski JG; Søderlund EJ; Bausano JA; Dybing E; Nelson SD Mutagenesis; 1987 Jul; 2(4):287-92. PubMed ID: 3325760 [TBL] [Abstract][Full Text] [Related]
2. Increased mutagenicity of 1,2-dibromo-3-chloropropane and tris(2,3-dibromopropyl)phosphate in Salmonella TA100 expressing human glutathione S-transferases. Simula TP; Glancey MJ; Söderlund EJ; Dybing E; Wolf CR Carcinogenesis; 1993 Nov; 14(11):2303-7. PubMed ID: 8242859 [TBL] [Abstract][Full Text] [Related]
3. Detection and mechanism of formation of the potent direct-acting mutagen 2-bromoacrolein from 1,2-dibromo-3-chloropropane. Omichinski JG; Soderlund EJ; Dybing E; Pearson PG; Nelson SD Toxicol Appl Pharmacol; 1988 Feb; 92(2):286-94. PubMed ID: 3277317 [TBL] [Abstract][Full Text] [Related]
4. Activation mechanism of tris(2,3-dibromopropyl)phosphate to the potent mutagen, 2-bromoacrolein. Nelson SD; Omichinski JG; Iyer L; Gordon WP; Soderlund EJ; Dybing E Biochem Biophys Res Commun; 1984 May; 121(1):213-9. PubMed ID: 6375666 [TBL] [Abstract][Full Text] [Related]
5. Comparative genotoxicity studies of the flame retardant tris(2,3-dibromopropyl)phosphate and possible metabolites. Holme JA; Søderlund EJ; Hongslo JK; Nelson SD; Dybing E Mutat Res; 1983 Dec; 124(3-4):213-24. PubMed ID: 6686285 [TBL] [Abstract][Full Text] [Related]
6. Metabolism in vitro of tris(2,3-dibromopropyl)-phosphate: oxidative debromination and bis(2,3-dibromopropyl)phosphate formation as correlates of mutagenicity and covalent protein binding. Søderlund EJ; Gordon WP; Nelson SD; Omichinski JG; Dybing E Biochem Pharmacol; 1984 Dec; 33(24):4017-23. PubMed ID: 6508849 [TBL] [Abstract][Full Text] [Related]
7. Mutagenicity of bis- and mono-(2,3-dibromopropyl)phosphate, and their salts used as flame retardants, in the Salmonella/microsome system. Nakamura A; Tateno N; Iwata T; Kojima S; Kaniwa M; Kawamura T Mutat Res; 1983 Apr; 117(1-2):1-8. PubMed ID: 6339901 [TBL] [Abstract][Full Text] [Related]
8. Mutagenic activation of tris(2,3-dibromopropyl)phosphate: the role of microsomal oxidative metabolism. Søderlund EJ; Nelson SD; Dybing E Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):112-21. PubMed ID: 40390 [TBL] [Abstract][Full Text] [Related]
9. Comparative genotoxicity and nephrotoxicity studies of the two halogenated flame retardants tris(1,3-dichloro-2-propyl)phosphate and tris(2,3-dibromopropyl)phosphate. Søderlund EJ; Dybing E; Holme JA; Hongslo JK; Rivedal E; Sanner T; Nelson SD Acta Pharmacol Toxicol (Copenh); 1985 Jan; 56(1):20-9. PubMed ID: 3883695 [TBL] [Abstract][Full Text] [Related]
10. Metabolism of selectively methylated and deuterated analogs of 1,2-dibromo-3-chloropropane: role in organ toxicity and mutagenicity. Låg M; Søderlund EJ; Omichinski JG; Nelson SD; Dybing E Chem Biol Interact; 1989; 69(1):33-44. PubMed ID: 2914329 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity studies on the mutagenicity of tris(2,3-dibromopropyl) phosphate (Tris-BP) and its metabolites in Salmonella. Zeiger E; Pagano DA; Nomeir AA Environ Mutagen; 1982; 4(3):271-7. PubMed ID: 7094911 [TBL] [Abstract][Full Text] [Related]
12. Mutagenic activity of halogenated propanes and propenes: effect of bromine and chlorine positioning. Låg M; Omichinski JG; Dybing E; Nelson SD; Søderlund EJ Chem Biol Interact; 1994 Oct; 93(1):73-84. PubMed ID: 8069951 [TBL] [Abstract][Full Text] [Related]
13. Mutagenicity of halogenated propanes and their methylated derivatives. Ratpan F; Plaumann H Environ Mol Mutagen; 1988; 12(2):253-9. PubMed ID: 3044786 [TBL] [Abstract][Full Text] [Related]
14. Tris(2,3-dibromopropyl) phosphate: mutagenicity of a widely used flame retardant. Prival MJ; McCoy EC; Gutter B; Rosendranz HS Science; 1977 Jan; 195(4273):76-8. PubMed ID: 318761 [TBL] [Abstract][Full Text] [Related]
15. Lack of mammalian mutagenicity of the potent bacterial mutagen tris(2,3-dibromopropyl) phosphate and its metabolite 2-bromoacrolein. van Beerendonk GJ; Klein JC; Tijdens RB; Lichtenauer-Kaligis EG; Tasseron-de Jong JG; Meerman JH Mutat Res; 1998 Jul; 415(3):201-11. PubMed ID: 9714806 [TBL] [Abstract][Full Text] [Related]
16. Different mechanisms are involved in DNA damage, bacterial mutagenicity and cytotoxicity induced by 1,2-dibromo-3-chloropropane in suspensions of rat liver cells. Holme JA; Søderlund EJ; Brunborg G; Omichinski JG; Bekkedal K; Trygg B; Nelson SD; Dybing E Carcinogenesis; 1989 Jan; 10(1):49-54. PubMed ID: 2642751 [TBL] [Abstract][Full Text] [Related]
17. Mutagen activation of 1,2-dibromo-3-chloropropane by cytosolic glutathione S-transferases and microsomal enzymes. Miller GE; Brabec MJ; Kulkarni AP J Toxicol Environ Health; 1986; 19(4):503-18. PubMed ID: 3537323 [TBL] [Abstract][Full Text] [Related]
18. Renal necrosis and DNA damage caused by selectively deuterated and methylated analogs of 1,2-dibromo-3-chloropropane in the rat. Omichinski JG; Brunborg G; Søderlund EJ; Dahl JE; Bausano JA; Holme JA; Nelson SD; Dybing E Toxicol Appl Pharmacol; 1987 Dec; 91(3):358-70. PubMed ID: 3424370 [TBL] [Abstract][Full Text] [Related]
19. Disposition of the flame retardant, tris(1,3-dichloro-2-propyl) phosphate, in the rat. Lynn RK; Wong K; Garvie-Gould C; Kennish JM Drug Metab Dispos; 1981; 9(5):434-41. PubMed ID: 6117442 [TBL] [Abstract][Full Text] [Related]
20. Metabolism, distribution, and excretion of the flame retardant, tris(2,3-dibromopropyl) phosphate (tris-bp) in the rat: identification of mutagenic and nephrotoxic metabolites. Lynn RK; Garvie-Gould C; Wong K; Kennish JM Toxicol Appl Pharmacol; 1982 Mar; 63(1):105-19. PubMed ID: 7071866 [No Abstract] [Full Text] [Related] [Next] [New Search]